Oracle and Baylor College of Medicine Collaborate to Advance Research into Alcohol-related Liver Disease

Core Insights - Oracle Health and Baylor College of Medicine are collaborating to advance research and clinical insights into alcohol-related liver disease (ALD), which is rapidly increasing as a cause of liver-related illness and mortality in the U.S. [1][4] Company Collaboration - Baylor College of Medicine will utilize Oracle Health's AI data platform and real-world data (RWD), which includes over 120 million longitudinal anonymized patient records, to create one of the largest ALD cohorts in the nation [2][3] - The goal is to expand the RWD cohort to over one million patients, facilitating research aimed at earlier identification of ALD and improving understanding of disease progression [2][3] Research and Public Health Impact - The collaboration aims to empower clinicians with actionable insights derived from comprehensive datasets and AI agents, which can enhance patient outcomes and support public health strategies to mitigate the burden of ALD [3][4] - Recent studies indicate a rising prevalence of alcohol-related liver disease in the U.S., particularly among younger populations, highlighting the urgency of this research initiative [4]